Your Messages Inbox
Your Article Summary
See Latest ArticlesBiopure Corporation Receives Notice of Delisting from Nasdaq
BioPure, 07/20/09
Biopure Corporation announced that it has received notice from The Nasdaq Stock Market, by letter dated July 2009, that its common stock would be delisted from Nasdaq. The notice stated that because of concerns raised by the Company's filing for protection under Chapter 11 of the Bankruptcy Code, trading would be suspended at the opening of business on July 2009.
Today in Regulatory Issues...keeping you current
Receive free subspecialty "5-minute updates" via email
Mandatory Disclosure of Pharmaceutical Industry-Funded Events for Health Professionals
PLoS Medicine, 12/02/09
FDA drug approval intervals from 1997 to 2006: analysis and comparison during information technology implementation
International Journal of Electronic Healthcare , 12/01/09
Regulatory Update: GSK files Rotarix for prevention of rotavirus in Japan
GlaxoSmithKline, 12/01/09
Article Search
Sponsor